GlassScriptPhysician profile
Angel Ignacio Blanco
NPI 1447240593
$597.08
in general payments reported to CMS, 2019-2025
9 companies · $240 in 2025
The $240 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24.81 · 2021: $14.00 · 2022: $166 · 2023: $137 · 2024: $15.60 · 2025: $240.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $392.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $391.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $198.09 | 2022-2024 | Aria Radiation Therapy Management Software, Somatom Go.Top |
| Novocure INC. | $145.05 | 2022-2025 | Optune Gio |
| Tactile Systems Technology INC | $70.93 | 2025 | Nimbl, Flexitouch Plus |
| Novartis Pharmaceuticals Corporation | $53.98 | 2025 | |
| Blue Earth Diagnostics | $39.80 | 2025 | Posluma |
| Astrazeneca Pharmaceuticals LP | $25.62 | 2025 | Tagrisso |
| Varian Medical Systems, INC. | $24.81 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $24.80 | 2025 | Libtayo |
| Carbofix Spine INC | $14.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angel Blanco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.